UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Prevention of accidental needle sticks before the Directive 2010/32/EU in a sample of Italian hospitals

Medicina del lavoro, 2015-05, Vol.106 (3), p.186

2015

Volltextzugriff (PDF)

Long-Term Carcinogenicity Bioassays on Three Chlorofluorocarbons (Trichlorofluoromethane, FC11; Dichlorodifluoromethane, FC12; Chlorodifluoromethane, FC22) Administered by Inhalation to Sprague-Dawley Rats and Swiss Mice

Annals of the New York Academy of Sciences, 1988, Vol.534 (1), p.261-282

1988

Volltextzugriff (PDF)

First experimental evidence of the carcinogenic effects of vinylidene fluoride; long-term bioassays on Sprague-Dawley rats by oral administration

Medicina del lavoro, 1979-09, Vol.70 (5), p.363

1979

Volltextzugriff (PDF)

MORE THERAPEUTIC ALTERNATIVES FOR CHRONIC IDIOPATHIC URTICARIA?

Annals of allergy, asthma, & immunology, 2008-11, Vol.101 (5), p.555-555

2008

Volltextzugriff (PDF)

Computer simulation of continuous arteriovenous hemofiltration

Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1988, p.1314-1316 vol.3

1988

Volltextzugriff (PDF)

Risks faced by laboratory workers in the AIDS era

Journal of biological regulators and homeostatic agents, 2001-07, Vol.15 (3), p.243

2001

Volltextzugriff (PDF)

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

Hepatology (Baltimore, Md.), 2016-03, Vol.63 (3), p.827-838

2016

Volltextzugriff (PDF)

Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: a prospective pilot study

Digestive and liver disease, 2024-02, Vol.56, p.S53

2024

Volltextzugriff (PDF)

Do ACE inhibitors have a role in preventing drug-related proteinuria in advanced HCC patients?

Digestive and liver disease, 2024-02, Vol.56, p.S92

2024

Volltextzugriff (PDF)

189P The synergic effect of metformin and atezolizumab/bevacizumab in diabetic HCC patients: A retrospective study from ARTE multicentric Italian dataset

Annals of oncology, 2024-06, Vol.35, p.S85-S85

2024

Volltextzugriff (PDF)

OC.11.6: PROSPECTIVE 5-YEAR FOLLOW-UP STUDY OF SPLEEN STIFFNESS MEASUREMENT WITH A SPLEEN-DEDICATED MODULE (SSM@100HZ) FOR PREDICTING HEPATIC DECOMPENSATION IN CACLD: COMPETITIVE RISK ANALYSIS

Digestive and liver disease, 2024-04, Vol.56, p.S186-S187

2024

Volltextzugriff (PDF)

OC.05.1: COMPETITIVE RISK ANALYSIS OF SPLEEN STIFFNESS MEASUREMENT WITH A SPLEEN-DEDICATED MODULE (SSM@100HZ) FOR PREDICTING DE-NOVO HCC OCCURRENCE IN CACLD PATIENTS: A PROSPECTIVE 5-YEAR FOLLOW-UP STUDY

Digestive and liver disease, 2024-04, Vol.56, p.S148-S149

2024

Volltextzugriff (PDF)

Prospective 5-Year Follow-up Study of Spleen Stiffness Measurement with a Spleen-Dedicated Module (SSM@100Hz) for Predicting Hepatic Decompensation in cACLD: Competitive Risk Analysis

Digestive and liver disease, 2024-02, Vol.56, p.S62-S63

2024

Volltextzugriff (PDF)

Competitive Risk Analysis of Spleen Stiffness Measurement with a Spleen-Dedicated Module (SSM@100Hz) for Predicting de-novo HCC Occurrence in cACLD Patients: A Prospective 5-Year Follow-up Study

Digestive and liver disease, 2024-02, Vol.56, p.S80-S81

2024

Volltextzugriff (PDF)

P-57 Atezolizumab in combination with bevacizumab in patients with unresectable HCC previously untreated with systemic therapy: Interim analysis results from phase IIIb Italian AMETHISTA trial

Annals of oncology, 2023-06, Vol.34, p.S34-S34

2023

Volltextzugriff (PDF)

Efficacy and safety of atezolizumab/bevacizumab for hepatocellular carcinoma in a real-life prospective cohort: data from a multicenter collaborative study

Digestive and liver disease, 2024-02, Vol.56, p.S85-S86

2024

Volltextzugriff (PDF)

The synergic effect of metformin with atezolizumab/ bevacizumab in masld hcc patients: a retrospective study from arte multicentric Italian dataset

Digestive and liver disease, 2024-02, Vol.56, p.S89-S90

2024

Volltextzugriff (PDF)

Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma

Digestive and liver disease, 2024-02, Vol.56, p.S87

2024

Volltextzugriff (PDF)

T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA

Digestive and liver disease, 2022-05, Vol.54, p.S147-S148

2022

Volltextzugriff (PDF)

Sensitivity of autologous serum skin test for chronic autoimmune urticaria

Journal of the European Academy of Dermatology and Venereology, 2009-08, Vol.23 (8), p.958-959

2009

Volltextzugriff (PDF)

A seroimmunological profile of erosive hand osteoarthritis

Acta reumatológica portuguesa, 2013-01, Vol.38 (1), p.39

2013

Volltextzugriff (PDF)

Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis

Acta clinica belgica (English ed. Online), 2011-01, Vol.66 (1), p.55

2011

Volltextzugriff (PDF)

Possible role of pirenzepine on the release of pancreatic polypeptide in duodenal ulcer patients: preliminary results of a randomized cross-over study

International journal on tissue reactions, 1983, Vol.5 (4), p.379

1983

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(22)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(7)
Life Sciences & Biomedicine
(6)
Science & Technology
(6)
Male
(5)
Female
(4)
Middle Aged
(3)
Aged
(2)
Aged, 80 And Over
(2)
Animals
(2)
Immunology
(2)
Rats
(2)
Urticaria - Immunology
(2)
Acquired Immunodeficiency Syndrome - Prevention & Control
(1)
Acquired Immunodeficiency Syndrome - Transmission
(1)
Administration, Inhalation
(1)
Administration, Oral
(1)
Adrenal Gland Neoplasms - Chemically Induced
(1)
Adult
(1)
Aids
(1)
Algorithms
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Prevention of accidental needle sticks before the Directive 2010/32/EU in a sample of Italian hospitals

Long-Term Carcinogenicity Bioassays on Three Chlorofluorocarbons (Trichlorofluoromethane, FC11; Dichlorodifluoromethane, FC12; Chlorodifluoromethane, FC22) Administered by Inhalation to Sprague-Dawley Rats and Swiss Mice

First experimental evidence of the carcinogenic effects of vinylidene fluoride; long-term bioassays on Sprague-Dawley rats by oral administration

MORE THERAPEUTIC ALTERNATIVES FOR CHRONIC IDIOPATHIC URTICARIA?

Computer simulation of continuous arteriovenous hemofiltration

Risks faced by laboratory workers in the AIDS era

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: a prospective pilot study

Do ACE inhibitors have a role in preventing drug-related proteinuria in advanced HCC patients?

189P The synergic effect of metformin and atezolizumab/bevacizumab in diabetic HCC patients: A retrospective study from ARTE multicentric Italian dataset

OC.11.6: PROSPECTIVE 5-YEAR FOLLOW-UP STUDY OF SPLEEN STIFFNESS MEASUREMENT WITH A SPLEEN-DEDICATED MODULE (SSM@100HZ) FOR PREDICTING HEPATIC DECOMPENSATION IN CACLD: COMPETITIVE RISK ANALYSIS

OC.05.1: COMPETITIVE RISK ANALYSIS OF SPLEEN STIFFNESS MEASUREMENT WITH A SPLEEN-DEDICATED MODULE (SSM@100HZ) FOR PREDICTING DE-NOVO HCC OCCURRENCE IN CACLD PATIENTS: A PROSPECTIVE 5-YEAR FOLLOW-UP STUDY

Prospective 5-Year Follow-up Study of Spleen Stiffness Measurement with a Spleen-Dedicated Module (SSM@100Hz) for Predicting Hepatic Decompensation in cACLD: Competitive Risk Analysis

Competitive Risk Analysis of Spleen Stiffness Measurement with a Spleen-Dedicated Module (SSM@100Hz) for Predicting de-novo HCC Occurrence in cACLD Patients: A Prospective 5-Year Follow-up Study

P-57 Atezolizumab in combination with bevacizumab in patients with unresectable HCC previously untreated with systemic therapy: Interim analysis results from phase IIIb Italian AMETHISTA trial

Efficacy and safety of atezolizumab/bevacizumab for hepatocellular carcinoma in a real-life prospective cohort: data from a multicenter collaborative study

The synergic effect of metformin with atezolizumab/ bevacizumab in masld hcc patients: a retrospective study from arte multicentric Italian dataset

Management of portal hypertension in patients receiving atezolizumab-bevacizumab for hepatocellular carcinoma

T.08.3 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND HEPATOCELLULAR CARCINOMA

Sensitivity of autologous serum skin test for chronic autoimmune urticaria

A seroimmunological profile of erosive hand osteoarthritis

Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis

Possible role of pirenzepine on the release of pancreatic polypeptide in duodenal ulcer patients: preliminary results of a randomized cross-over study

Suchergebnisse filtern